Results after intraoperative open and endovascular revascularization of acute mesenteric ischemia requiring a

Marvin Kapalla1, Rahul Choubey2, Jürgen Weitz2

  • 1Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Dresden, TU, Germany. Marvin.Kapalla@uniklinikum-dresden.de.

PubMed
Abstract

Insights

Acute mesenteric ischemia (AMI) treatment outcomes were similar for open surgery and endovascular approaches. Advanced disease and comorbidities increased mortality risk in AMI patients.

Area of Science:

  • Vascular Surgery
  • Gastroenterology
  • Interventional Radiology

Background:

  • Acute mesenteric ischemia (AMI) presents diagnostic challenges and high mortality.
  • Selection bias complicates comparisons between endovascular and open surgical treatments for AMI.
  • Evaluating treatment outcomes for AMI requires careful consideration of patient baseline status.

Purpose of the Study:

  • To compare outcomes of open surgical versus endovascular treatment for AMI in patients requiring laparotomy.
  • To assess the efficacy of an endovascular-first strategy in specific clinical scenarios of AMI.
  • To identify risk factors associated with mortality in AMI patients.

Main Methods:

  • Retrospective review of clinical data from 74 AMI patients (2007-2021).
  • Comparison of in-hospital mortality between open surgical (OT) and endovascular (ET) approaches.
  • Univariate and multivariate analyses to identify mortality risk factors.

Main Results:

  • In-hospital mortality was 43% overall (41% OT vs. 53.8% ET; P=0.54).
  • Independent risk factors for mortality included pneumatosis intestinalis, elevated lactate, and ischemic bowel sections.
  • Patient age, severe congestive heart failure, and atrial fibrillation were associated with increased mortality on univariate analysis.

Conclusions:

  • Morbidity and mortality rates for AMI remain high.
  • Open and endovascular therapies yielded similar outcomes in patients undergoing laparotomy.
  • Advanced disease stage and cardiovascular comorbidities predict adverse outcomes in AMI.